Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Relmada Therapeutics Inc., 3 years.
Relmada Therapeutics Inc.
Director · COO
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2025 | Relmada Therapeutics Inc. | Open-market purchase | +90,000 | $2.20 | $198,000 |
| May 16, 2025 | Relmada Therapeutics Inc. | Open-market purchase | +200,000 | $0.43 | $86,000 |
| Sep 9, 2024 | Relmada Therapeutics Inc. | Open-market purchase | +25,000 | $2.59 | $64,750 |
Questions about Paul Edward Kelly
What boards is Paul Edward Kelly on?
Paul Edward Kelly sits on the board of Relmada Therapeutics Inc.
How long has Paul Edward Kelly served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.